You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Prasterone

Showing 1 - 25 of 25
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dyspareunia Trial in San Diego (Prasterone)

Completed
  • Dyspareunia
  • Prasterone
  • San Diego, California
    San Diego Sexual Medicine
Jun 8, 2022

Vulvar Atrophy, Breast Cancer, Genitourinary Syndrome of Menopause Trial in Barcelona (Prasterone (DHEA), Micronized)

Completed
  • Vulvar Atrophy
  • +2 more
  • Prasterone (DHEA), Micronized
  • Barcelona, Spain
    Hospital Clínic de Barcelona
Feb 20, 2022

Postmenopausal Vulvovaginal Atrophy Trial (intravaginal prasterone, Placebo ovules)

Not yet recruiting
  • Postmenopausal Vulvovaginal Atrophy
  • intravaginal prasterone
  • Placebo ovules
  • (no location specified)
Jul 20, 2021

Vulvovaginal Atrophy Trial in Madrid (Prasterone 6.5 MG, Placebo)

Recruiting
  • Vulvovaginal Atrophy
  • Prasterone 6.5 MG
  • Placebo
  • Madrid, Spain
    Instituto Palacios
May 28, 2021

Vaginal Atrophy in Breast Cancer Patients Trial (Placebo, Prasterone (DHEA))

Withdrawn
  • Vaginal Atrophy in Breast Cancer Patients
  • Placebo
  • Prasterone (DHEA)
  • (no location specified)
Jul 29, 2020

Hypoactive Sexual Desire Disorder (HSDD) Trial in United States (Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal

Withdrawn
  • Hypoactive Sexual Desire Disorder (HSDD)
  • Placebo Vaginal Insert
  • Prasterone 6.5 mg (0.50%) Vaginal Insert
  • Huntsville, Alabama
  • +9 more
Jul 29, 2020

Hypoactive Sexual Desire Disorder Trial in Canada, United States (Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal

Completed
  • Hypoactive Sexual Desire Disorder
  • Placebo Vaginal Insert
  • Prasterone 6.5 mg (0.50%) Vaginal Insert
  • Huntsville, Alabama
  • +68 more
Apr 7, 2021

Chinese Genitourinary Syndrome of Menopause Treated With Vaginal

Recruiting
  • Genitourinary Syndrome of Menopause
  • vaginal dehydroepiandrosterone
  • Hong Kong, Hong Kong
    The Chinese University of Hong Kong
Aug 14, 2022

Vulvovaginal Atrophy, Genitourinary Syndrome of Menopause Trial in Stockholm (vaginal estradiol 10 µg, vaginal DHEA 6.5 mg)

Recruiting
  • Vulvovaginal Atrophy
  • Genitourinary Syndrome of Menopause
  • vaginal estradiol 10 μg
  • vaginal DHEA 6.5 mg
  • Stockholm, Sweden
    Karolinska University Hospital
Oct 15, 2022

Menopause, Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy Trial in Washington, New York (Intrarosa, Placebos)

Unknown status
  • Menopause
  • +4 more
  • Washington, District of Columbia
  • +1 more
Jan 30, 2019

Vulvo-vaginal Atrophy, Genitourinary Syndrome of Menopause Trial in Brussels (Dynamic Quadripolar Radio-Frequency treatment,

Terminated
  • Vulvo-vaginal Atrophy
  • Genitourinary Syndrome of Menopause
  • Dynamic Quadripolar Radio-Frequency treatment
  • pH-Cream
  • Brussels, Belgium
  • +4 more
Mar 9, 2022

Female Urogenital Diseases, Breast Cancer Female Trial (C02 microablative laser, Regenerative topical treatment)

Not yet recruiting
  • Female Urogenital Diseases
  • Breast Cancer Female
  • C02 microablative laser
  • Regenerative topical treatment
  • (no location specified)
Nov 28, 2022

Anorexia Nervosa Trial in Boston (Hormone replacement therapy (estrogen/progestin), Placebo (Sugar Pill), Dehydroepiandrosterone

Completed
Has Results
  • Anorexia Nervosa
  • Hormone replacement therapy (estrogen/progestin)
  • +2 more
  • Boston, Massachusetts
    Children's Hospital Boston
Mar 15, 2018

Vaginal Atrophy Trial in Canada, United States (Placebo, DHEA (0.25%), DHEA (0.5%))

Completed
Has Results
  • Vaginal Atrophy
  • Placebo
  • +3 more
  • Cleveland, Ohio
  • +7 more
Jul 28, 2017

Breast Cancer, Gynecologic Cancer Trial in United States (prasterone, )

Completed
Has Results
  • Breast Cancer
  • Gynecologic Cancer
  • prasterone
  • placebo
  • Scottsdale, Arizona
  • +279 more
Jan 22, 2019

Vaginal Atrophy Trial in Quebec (DHEA, Placebo)

Completed
  • Vaginal Atrophy
  • Quebec, Canada
    Clinique des traitements hormonaux CHUL Research Center
Apr 6, 2017

Vaginal Atrophy Trial in Canada, United States (Placebo, Prasterone (DHEA))

Completed
Has Results
  • Vaginal Atrophy
  • Placebo
  • Prasterone (DHEA)
  • Montgomery, Alabama
  • +37 more
May 30, 2017

Vaginal Atrophy Trial in Canada, United States (Placebo, DHEA)

Completed
Has Results
  • Vaginal Atrophy
  • Montgomery, Alabama
  • +32 more
May 31, 2017

Vaginal Atrophy Trial in Canada, United States (Placebo, DHEA)

Completed
Has Results
  • Vaginal Atrophy
  • Montgomery, Alabama
  • +41 more
Jun 8, 2017

Vaginal Atrophy Trial in Canada, United States (DHEA)

Completed
Has Results
  • Vaginal Atrophy
  • Montgomery, Alabama
  • +40 more
Sep 15, 2017

Lupus Nephritis, Lupus Erythematosus, Systemic Trial in Mexico, United States (abatacept, cyclophosphamide, azathioprine)

Completed
Has Results
  • Lupus Nephritis
  • Lupus Erythematosus, Systemic
  • Birmingham, Alabama
  • +22 more
Jan 15, 2016

Vasomotor Symptoms, Hot Flushes Trial in Canada (Placebo, DHEA and Acolbifene)

Completed
  • Vasomotor Symptoms
  • Hot Flushes
  • Placebo
  • DHEA and Acolbifene
  • Bathurst, New Brunswick, Canada
  • +14 more
Dec 10, 2013

Multiple Myeloma and Plasma Cell Tumor Trial in Scottsdale, Jacksonville, Rochester (clarithromycin, prasterone)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Scottsdale, Arizona
  • +2 more
Aug 2, 2011

Systemic Lupus Erythematosus Trial in Mexico, United States (Prasterone (GL701))

Completed
  • Systemic Lupus Erythematosus
  • Prasterone (GL701)
  • Tucson, Arizona
  • +21 more
Jan 10, 2008

Lupus Trial in Mexico, United States (Prasterone (GL701))

Unknown status
  • Lupus
  • Prasterone (GL701)
  • Tucson, Arizona
  • +25 more
Dec 26, 2007